|
⚲
|
| TCW Alpha Core CI LP | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001457925 |
| Sale | 2009-01-02 ($23.6 M Sold) |
| Fund | |
| Phone | 2132440000 |
| Address | 865 S Figueroa Street Los Angeles, 90017 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Robert Beyer | |
| Michael Cahill | |
| Richard Villa | |
| Hilary Lord | |
| TCW Asset Management Company International Limited | |
| TCW Funds Distributors | |
| David Devito | |
| Jeffrey Gundlach |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
JSS Capital Opportunity Fund 1 LLC
✚
|
0.0 | |
|
JS Venture Fund LLC Series A21
✚
|
0.0 | |
|
JTAG Oregon, LLC
✚
|
0.0 | |
|
JTS Capital SPIV, LLC
✚
|
0.0 | |
|
JU-0409 Fund I, a series of Susan Su Ventures, LP
✚
|
0.0 | |
|
JU-0820 Fund I, a series of Riverside Ventures, LP
✚
|
0.0 | |
|
JU-1214 Fund VI, a series of Heron Rock AL Access Funds, LP
✚
|
0.0 | |
|
Jubliee, Inc.
✚
|
0.0 | |
|
Jude Gomila, LP - E1
✚
|
0.0 | |
|
JSK Therapeutics, Inc.
✚
|
0.0 |